Introduction
The coronavirus caused a number of unknown pneumonia cases that showing clinically similar to viral pneumonia in Wuhan, a city in the Hubei Province of China, in December 2019 (1). On January 30, 2020, the World Health Organization (WHO) announced that the new coronavirus (2019-nCoV) was a public health emergency of international concern (PHEIC). The virus spread rapidly all over the world and the number of cases began to increase in the other countries in February 2020 (2). The first case in our country was announced on March 11, 2020. Until this date, the number of cases detected in the world was 125900, but now (2 June) is 6.378M (3). Currently, knowledge on the epidemiology and clinical features of pneumonia in pregnancy caused by COVID-19 is limited. For this reason, nowadays, there is a need for all information about COVID-19 in pregnancy.
Effective obstetric therapy is required in these pregnant women and is key to optimizing prognosis for both mother and child. Care should be individualized in determining the time of delivery, evaluating the c-section indications, preparing the delivery room to prevent infection, choosing the type of anesthesia and managing the newborn. Birth and treatment experiences are limited for pregnant women who have had the disease in the last 3 months (4, 5).
In our study, we aim to define the epidemiological, clinical, laboratory and radiological features, maternal and neonatal outcomes and treatment of pregnant women confirmed to have SARS-CoV-2 infection.